Lifecore Biomedical, Inc. \De\ (LFCR) — 10-Q Filings
All 10-Q filings from Lifecore Biomedical, Inc. \De\. Browse 4 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (4)
-
Lifecore Narrows Losses, Boosts Revenue Amid Capacity Expansion
— Nov 6, 2025 Risk: medium
LIFECORE BIOMEDICAL, INC. reported a net loss of $9.991 million for the three months ended September 30, 2025, an improvement from the $16.230 million net loss -
LifeCore Biomedical Files 10-Q for Feb 23, 2025
— Apr 3, 2025 Risk: low
LifeCore Biomedical, Inc. filed its 10-Q for the period ending February 23, 2025. The company, formerly known as Landec Corp, is incorporated in Delaware and op -
LifeCore Biomedical Files 10-Q for Nov 24, 2024
— Jan 2, 2025 Risk: low
LifeCore Biomedical, Inc. filed a 10-Q for the period ending November 24, 2024. The company, formerly known as Landec Corp, is incorporated in Delaware and oper -
LifeCore Biomedical Files 10-Q
— Oct 4, 2024 Risk: low
LifeCore Biomedical, Inc. reported its quarterly results for the period ending August 25, 2024. The company's fiscal year ends on May 25th. Specific financial f
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX